Novo Nordisk A/S
NYSE:NVO
Novo Nordisk A/S
NYSE:NVO
Price:
36.04
USD
-0.99%
Market Closed
Market Cap:
$160.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novo Nordisk A/S
NYSE:NVO
|
DK |
|
I
|
Iveric Bio Inc
F:O2T
|
US |
|
N
|
Noble Group Holdings Ltd
SGX:CGP
|
HK |
|
B
|
B Communications Ltd
TASE:BCOM
|
IL |
|
E
|
Evrofarma SA
ATHEX:EVROF
|
GR |
|
Ops Ecom SpA
MIL:OEC
|
IT |
|
C
|
CelcomDigi Bhd
KLSE:CDB
|
MY |
|
Pharmanutra SpA
MIL:PHN
|
IT |
|
SOPerior Fertilizer Corp
OTC:POTRF
|
CA |
|
Akcansa Cimento Sanayi ve Ticaret AS
IST:AKCNS.E
|
TR |
|
Mill City Ventures III Ltd
NASDAQ:MCVT
|
US |
|
H
|
Huhtamaki Oyj
OMXH:HUH1V
|
FI |
|
AltC Acquisition Corp
NYSE:OKLO
|
US |
|
P
|
Polygon Real Estate Ltd
TASE:POLY
|
IL |
|
O
|
Ourpalm Co Ltd
SZSE:300315
|
CN |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
Visiomed Group SA
PAR:ALVMG
|
FR |
|
Y
|
Youngchang Chemical Co Ltd
KOSDAQ:112290
|
KR |
|
Bharat Bijlee Ltd
NSE:BBL
|
IN |
|
A
|
Activision Blizzard Inc
LSE:0H8X
|
US |
|
B
|
Bertam Alliance Bhd
KLSE:BERTAM
|
MY |
|
Ginting Jaya Energi Tbk PT
IDX:WOWS
|
ID |
|
Europap Tezol Kagit Sanayi Ve Ticaret AS
IST:TEZOL.E
|
TR |
|
EVgo Inc
NASDAQ:EVGO
|
US |
Multiples-Based Value
The Multiples-Based Value of one
NVO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 36.04 USD,
Novo Nordisk A/S
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NVO Multiples-Based Value
LOCKED
Multiples Across Competitors
NVO Competitors Multiples
Novo Nordisk A/S Competitors
Novo Nordisk A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
NYSE:NVO
|
1T USD | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 | |
| FR |
|
Sanofi SA
PAR:SAN
|
99.1B EUR | 2.1 | 12.7 | 10.6 | 10.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
